Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:12:14.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:27:32.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The publications note at the bottom was updated to indicate PubMed-listed publications are automatically filled from PubMed and may not be about the study, and the revision version changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:27:33.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Removal of a site-wide banner about government funding and operating status from the page. This does not affect the study details or the core information presented about the Nivo40 trial.
    Difference
    0.4%
    Check dated 2025-11-18T06:51:07.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The screenshots show only UI/layout updates with no changes to the study's core details (eligibility criteria, endpoints, or results). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:46:07.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page now includes a funding-related operating status notice and a new version badge (v3.2.0), replacing the previous v3.1.0. This signals updated operational status and a software release, altering expectations for data processing and reliability.
    Difference
    5%
    Check dated 2025-10-06T04:59:31.000Z thumbnail image

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.